1. The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors. (6th July 2020) Authors: Paul, Barry; Zhao, Yue; Loitsch, Gavin; Feinberg, Daniel; Mathews, Parker; Barak, Ian; Dupuis, Megan; Li, Zhiguo; Rein, Lindsay; Wang, Endi; Kang, Yubin Journal: Cancer medicine Issue: Volume 9:Number 16(2020) Page Start: 5869 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗